Live Breaking News & Updates on Clinical Outcomes|Page 9

Stay updated with breaking news from Clinical outcomes. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Vaxxinity's Cholesterol Vaccine Candidate Successfully Lowers LDL-C: Preclinical Data Published

Vaxxinity's Cholesterol Vaccine Candidate Successfully Lowers LDL-C: Preclinical Data Published
tmcnet.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from tmcnet.com Daily Mail and Mail on Sunday newspapers.

Mark Joinnides , Jon Yu , Vaxxinity Inc , Exchange Commission On , Journal Of Lipid Research Volume , World Health Organization , Preclinical Data , Lipid Researchindicate , Lipid Research , Private Securities Litigation Reform Act , Annual Report , Exchange Commission , World Health , Clinical Outcomes , Cardiovascular Outcomes , Acute Coronary ,

Health outcomes after myocardial infarction: A population study of 56 million people in England

Using hospital records of 34 million adults admitted to hospitals in England, Marlous Hall and team examine the long-term risk of major health outcomes following myocardial infarction. ....

United Kingdom , United States , South Africa , Northern Ireland , Andrep Kengne , Charlotte Sturley , Daiichi Sankyo , Quality Indicator Committee , United Kingdom Phenotype Library , University Of Leeds , National Health Service , International Classification Of Disease , Leeds Analytic Secure Environment For Research , Clinical Research Training Fellowship , Raisio Group , Health Data Research United Kingdom , Alan Turing Institute , Boston Scientific , United Kingdom Myocardial Ischaemia National Audit Project , Indicator Advisory Committee , England Data Access Request Service , Office Of Population Censuses , British Heart Foundation , Wellcome Trust Sir Henry Postdoctoral Fellowship , Office For National Statistics , African Medical Research Council ,

Bipolar Disorder Research Roundup: February 9, 2024

What is new in research on bipolar disorder? ....

Research Roundup , Glucose Metabolism , Clinical Outcomes , Western China , Aripiprazole Once Monthly , Potential Biomarkers , Suicide Attempts , Del Favero Campbell ,

GSK's RSV vaccine for adults 50-59 at increased risk accepted by FDA for Priority Review

GSK plc's application to extend its RSV vaccine indication to adults aged 50-59 at risk has been accepted by the FDA for priority review. If approved, it would be the first vaccine for this population. The application is supported by positive phase III trial results. ....

Clin Virol , Richard Osei Yeboah , Drug Administration , Centers For Disease , Prescription Drug User Fee Act , Priority Review Voucher , Biologics License Application , Clin Infect , Clinical Outcomes , Respiratory Syncytial Virus , Prospective Multicenter , Immune Response , Vaccine Against Respiratory Syncytial Virus Given , Including Adults , Increased Risk , Older Adults , New Englj Med , Disease Control , Chronic Medical Conditions ,

GSK's RSV Vaccine, AREXVY, Accepted Under Priority Review in US for the Prevention of RSV Disease in Adults Aged 50-59 at Increased Risk -February 06, 2024 at 07:04 am EST

Application supported by positive results of a phase III trial showing immune response and acceptable tolerability profile in this population

Adults aged 50 and above with underlying medical. ....

United Kingdom , United Kingdom General , J Clin Virol , Richard Osei Yeboah , Saponiqx Inc , Centers For Disease , Agenus Inc , Antigenics Inc , Drug Administration , Priority Review , Respiratory Syncytial Virus Vaccine , Priority Review Voucher , Biologics License Application , Prescription Drug User Fee Act , Syncytial Virus Vaccine , Safety Information , Annual Report , West Road , Clin Infect , Clinical Outcomes , Respiratory Syncytial Virus , Prospective Multicenter , Immune Response , Vaccine Against Respiratory Syncytial Virus Given , Including Adults , Increased Risk ,